As our understanding of HCC continues to evolve, the Milan Criteria may be updated or supplemented with new selection guidelines. Advances in genomic profiling and immunotherapy are likely to play a role in refining patient selection for liver transplantation. Additionally, ongoing research into predictive biomarkers and improved imaging techniques may provide better tools for assessing which patients are most likely to benefit from a transplant.
